Recorded Presentation - Making Optimal Therapeutic Decisions in Patients with Advanced Renal Cell Carcinoma

This recorded webcast, with interactive Q&A and patient-physician video case studies, will address the application of existing and emerging clinical research data to make evidence-based selection of first-line therapy for treatment of advanced renal cell carcinoma, optimal subsequent lines of treatment, and toxicities of targeted therapies.

Target Audience

This webcast is designed to meet the educational needs of physicians, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Apply the existing and emerging clinical research data to make evidence-based selection of first-line therapy for treatment of advanced renal cell cancer
  • Select optimal subsequent lines of treatment to improve outcomes of patients with advanced RCC
  • Describe the toxicities of targeted therapies used in treatment of renal cell cancer and outline the strategies used to effectively manage them
Additional information
Supporters: 

This activity is supported by an educational grant from Pfizer.

Course summary
Available credit: 
  • 1.25 Participation
  • 1.18 Nurse
  • 1.25 Pharmacist
  • 1.25 Physician
Course opens: 
12/12/2013
Course expires: 
12/12/2014
Cost:
$0.00

Toni K. Choueiri, MD
Dana-Farber/Brigham and Women's Cancer Center

Laurie Appleby, NP
Dana-Farber/Brigham and Women's Cancer Center

Available Credit

  • 1.25 Participation
  • 1.18 Nurse
  • 1.25 Pharmacist
  • 1.25 Physician

Accreditation Period

Course opens: 
12/12/2013
Course expires: 
12/12/2014

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Flash Player and/or an HTML5 capable browser for video and audio playback
  • Adobe Reader for certificate viewing/printing